{"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":90}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
  • {"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Noto Sans KR","Nanum Barun Gothic"]}
    ×
    섹션 설정
    {"type":"img","src":"https://cdn.quv.kr/dftb6ow8k%2Fup%2F5c32ea85dae40_1920.png","height":50}
  • COMPANY
  • R&D PIPELINE
  • CRO SERVICES
  • CAREER
  • NEWS
  • CONTACT US
  • OUR COMPANY

    Company Introduction

    History

    RUDACURE

    2024

    02 Certification of Performance Sharing Companies

    03 RCI001 MFDS Phase 1 IND  Approval

    2023

    01 Licensed-out RCI001U to Hanlim pharmaceutical Co.

    02 A novel peptide and sue therof Patent Application

    03 Signed MOU with ONHEAL, ONHEALPET for joint development of veterinary drugs

           Attend Bio-Europe Spring(Basel, Switzerland)

    05 2023 Certification of Small Giant Corporate by the Ministry of Employment and Labor

           Signed MOU with Darae Biz for consulting about Special Listed Technology Growth IPO

           Attracted investment from Darae individaul investment association

    06 Attend 2023 ASCO(Americna Society of Clinical Incology, Chicago)

           Attend BIO-USA 2023(Boston) 

           Selected Incheon Startup Park Boost Startup Program

    07 Attend Inter-Biz 2023

           Certification of Performance Sharing Companies

    09 Attend the University of Utah Global Startup Outreach Program

           RCI001 Eye drop formulation Patent Application 

    10 Attend Global Innovation Roadshow(Singapore) 

           Selected SBA TIPS Program

    11 Won KICDC/Defy Pitch Competition 1st Prize 

           Attend Bio Europe Fall 2023(Munchen, Germany) 

           Attend ACR(American College of Reumatology) Convergence 2023(San Diego, USA)

           RCI001 formulation PCT application

           RCI001 derivative patent applicaiton

    12 Hanllym Univ. - EIONCELL CAR-T and ADC joint research

           Attracted investment from C&R Research, DreamCIS 

      

    2022

    01 Selected BIG3 Innovation Startup Package by the Ministry of SMEs and Startups

    03 Certification of Inno-Biz

    04 Selected to be a 2022 regular membership(Global) of Shinhan Square Bridge Incheon

    05 Attracted investment from Korea Venture Fund

           Certification of Small Giant Corporate by the Ministry of Employment and Labor

           Selected Smart-X Bio Hanlim pharmaceutical Co. Program

    06 Certification of Performance Sharing Companies

           RCI002 China Patent Application 

           Attend BIO-USA (San Diego) 

    07 Headquaters relocation(BRC) and open Seoul office

           RCI002 Japan Patent Application 

    08 Selected to be a cooperation company of  Korea Drug Development Fund

           Attend UKC 2022 (Washington D.C.) and won Start-up IR Competition SBA Award

    09 Attend RESI Conference (Boston) and won RESI Innovato's challenge 3rd prize

    10 Remodeling HQ office in Incheon

    11 Attend Tech Summit (Washington D.C.)

     

     

     

    2021

    01 Headquarters relocation (Incheon Startup Park)

    04 Licensed-out RCI001 to Hanlim pharmaceutical Co. for domestic rights 

    07 RCI002 PCT and US Patent Application

    08 RudaCure U.S.A. Establishment of U.S. Corporate

    09 Selected to be part of Bio I-Corps Program by the Minister of Science & Technology

           Attracted investments from Y&Archer and other individual investors

    10 Two trademark registrations

    11 Venture Investment Association (CKD Startup Investment) to attract investment

    12 RCI002 Domestic Patent Registration
           Atopic dermatitis/AMD before extension of applicability
           Full-time Toxicity and Effectiveness Test Research Service Expansion

    2020

    01 RCI002 Domestic Patent Application

    02 Selection of RCI001 New Research Projects

    06 RCI001 US Patent Registry

    11 RCI002 PCT Application and US Patent Application

     

    RCI003
    Atopic dermatitis drug screening and optimization
    RCI004
    metastatic cancer treatment drug screening

    2019

    01 Accreditation of the Institute of Corporate Affiliated Research Institut

    03 Agreement on Small and Medium Venture Performance Sharing Companies

    05 Certification of Venture Businesses

    11 Attract investment in technology guarantee

    12 Headquarters Extension

    2018

    07.23 Establishment of Rudacure co., ltd.

    {"google":["Noto Sans","Poppins","Roboto","Oswald"],"custom":["Nanum Square","Nanum Barun Gothic","Noto Sans KR"]}{"google":["Noto Sans","Poppins"],"custom":["Nanum Square","Nanum Barun Gothic","Noto Sans KR"]}
    {"google":[],"custom":["Noto Sans KR"]}